Cargando…

Comprehensive Evaluation of the Immune Risk Phenotype in Successfully Treated HIV-Infected Individuals

BACKGROUND: Despite successful treatment and CD4+ T-cell recovery, HIV-infected individuals often experience a profound immune dysregulation characterized by a persistently low CD4:CD8 T-cell ratio. This residual immune dysregulation is reminiscent of the Immune Risk Phenotype (IRP) previously assoc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ndumbi, Patricia, Gilbert, Louise, Tsoukas, Christos M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315523/ https://www.ncbi.nlm.nih.gov/pubmed/25647167 http://dx.doi.org/10.1371/journal.pone.0117039

Ejemplares similares

Delay in cART Initiation Results in Persistent Immune Dysregulation and Poor Recovery of T-Cell Phenotype Despite a Decade of Successful HIV Suppression
por: Ndumbi, Patricia, et al.
Publicado: (2014)

Improvements in Immune Function and Activation with 48-Week Darunavir/Ritonavir-Based Therapy: GRACE Substudy
por: Tsoukas, Christos, et al.
Publicado: (2013)

Immune correlates of CD4 decline in HIV-infected patients experiencing virologic failure before undergoing treatment interruption
por: Huang, Kenneth H, et al.
Publicado: (2008)

Evaluating Immune Dysregulation in Patients With COVID-19 Requires a More Accurate Definition of the CD45RA(+) T-cell Phenotype
por: Poloni, Chad, et al.
Publicado: (2020)

The Canadian HIV and aging cohort study - determinants of increased risk of cardio-vascular diseases in HIV-infected individuals: rationale and study protocol
por: Durand, Madeleine, et al.
Publicado: (2017)

HIV exposed seronegative (HESN) compared to HIV infected individuals have higher frequencies of telomeric Killer Immunoglobulin-like Receptor (KIR) B motifs; Contribution of KIR B motif encoded genes to NK cell responsiveness
por: Jackson, Elise, et al.
Publicado: (2017)

Replicative phenotyping adds value to genotypic resistance testing in heavily pre-treated HIV-infected individuals - the Swiss HIV Cohort Study
por: Fehr, Jan, et al.
Publicado: (2011)

Cellular Immune Responses and Viral Diversity in Individuals Treated during Acute and Early HIV-1 Infection
por: Altfeld, Marcus, et al.
Publicado: (2001)

The NLRP3 Inflammasome Is Upregulated in HIV-Infected Antiretroviral Therapy-Treated Individuals with Defective Immune Recovery
por: Bandera, Alessandra, et al.
Publicado: (2018)

Are the Healthy Vulnerable? Cytomegalovirus Seropositivity in Healthy Adults Is Associated With Accelerated Epigenetic Age and Immune Dysregulation
por: Poloni, Chad, et al.
Publicado: (2021)

Immunological age prediction in HIV-infected, ART-treated individuals
por: de Armas, Lesley R., et al.
Publicado: (2021)

Dynamics and epigenetic signature of regulatory T-cells following antiretroviral therapy initiation in acute HIV infection
por: Yero, Alexis, et al.
Publicado: (2021)

Evaluation of Rapid Progressors in HIV Infection as an Extreme Phenotype
por: Olson, Ashley D., et al.
Publicado: (2014)

Strongyloides stercoralis Hyperinfection in an HIV-Infected Patient Successfully Treated with Subcutaneous Ivermectin
por: Grossi, Paolo Antonio, et al.
Publicado: (2018)

Interferon-alpha, immune activation and immune dysfunction in treated HIV infection
por: Cha, Lilian, et al.
Publicado: (2014)

Different Plasma Markers of Inflammation Are Influenced by Immune Recovery and cART Composition or Intensification in Treated HIV Infected Individuals
por: Massanella, Marta, et al.
Publicado: (2014)

Residual Viremia in Treated HIV(+) Individuals
por: Conway, Jessica M., et al.
Publicado: (2016)

Treated HIV Infection Alters Phenotype but Not HIV-Specific Function of Peripheral Blood Natural Killer Cells
por: Zhao, Nancy Q., et al.
Publicado: (2020)

Prediction of virological failure in HIV-infected individuals treated with cART in Suriname
por: Bleijenberg, MP, et al.
Publicado: (2010)

Fecal Bacterial Communities in treated HIV infected individuals on two antiretroviral regimens
por: Pinto-Cardoso, Sandra, et al.
Publicado: (2017)

Extremely low viral reservoir in treated chronically HIV-1-infected individuals
por: Gálvez, Cristina, et al.
Publicado: (2020)

Plasma Metabolic Signature and Abnormalities in HIV-Infected Individuals on Long-Term Successful Antiretroviral Therapy
por: Babu, Hemalatha, et al.
Publicado: (2019)

Gut Bacteria Metabolism Impacts Immune Recovery in HIV-infected Individuals
por: Serrano-Villar, Sergio, et al.
Publicado: (2016)

Fecal Microbiota Composition Drives Immune Activation in HIV-infected Individuals
por: Neff, Charles Preston, et al.
Publicado: (2018)

Probiotics Reduce Inflammation in Antiretroviral Treated, HIV-Infected Individuals: Results of the “Probio-HIV” Clinical Trial
por: d’Ettorre, Gabriella, et al.
Publicado: (2015)

High Prevalence of Sarcopenia in HIV-Infected Individuals
por: Echeverría, Patricia, et al.
Publicado: (2018)

Integrative Analysis of Immunological Data to Explore Chronic Immune T-Cell Activation in Successfully Treated HIV Patients
por: Picat, Marie-Quitterie, et al.
Publicado: (2017)

Latent and Active Tuberculosis Infection Increase Immune Activation in Individuals Co-Infected with HIV()()()
por: Sullivan, Zuri A., et al.
Publicado: (2015)

Evaluation of Cardiovascular Disease Risk in HIV-1–Infected Patients Treated with Darunavir
por: Opsomer, Magda, et al.
Publicado: (2018)

HIV tropism switch in archived DNA of HIV-HCV subjects successfully treated with direct-acting antivirals for HCV infection
por: Basso, Monica, et al.
Publicado: (2021)

Peripheral blood CD4(+)CCR6(+) compartment differentiates HIV-1 infected or seropositive elite controllers from long-term successfully treated individuals
por: Svensson Akusjärvi, Sara, et al.
Publicado: (2022)

Trans cohort metabolic reprogramming towards glutaminolysis in long-term successfully treated HIV-infection
por: Mikaeloff, Flora, et al.
Publicado: (2022)

Kawasaki disease and MIS-C share a host immune response
por: Tsoukas, Paul, et al.
Publicado: (2022)

Successful treatment of acrodermatitis continua of Hallopeau with tildrakizumab: A case report
por: Nguyen, Alex, et al.
Publicado: (2023)

Increased ex vivo cell death of central memory CD4 T cells in treated HIV infected individuals with unsatisfactory immune recovery
por: Massanella, Marta, et al.
Publicado: (2015)

Allergic reactions to the coronavirus disease 2019 vaccine (ARCOV) study: The McGill University Health Centre experience
por: ALMuhizi, Faisal, et al.
Publicado: (2022)

Innate immune mechanisms to oral pathogens in oral mucosa of HIV-infected individuals
por: Weinberg, Aaron, et al.
Publicado: (2020)

The accumulation of plasma acylcarnitines are associated with poor immune recovery in HIV-infected individuals
por: Qian, Shi, et al.
Publicado: (2021)

HIV-1 Subtype C-Infected Individuals Maintaining High Viral Load as Potential Targets for the “Test-and-Treat” Approach to Reduce HIV Transmission
por: Novitsky, Vladimir, et al.
Publicado: (2010)

Hepatic fibrosis and immune phenotype vary by HCV viremia in HCV/HIV co-infected subjects: A Women's interagency HIV study
por: Desai, Seema N., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_5ec07ei83lklskftev0s7i4mkk